CA2387529A1 — Biphenyl derivatives as nhe-3 inhibitors
Assigned to Merck Patent GmbH · Expires 2001-03-29 · 25y expired
What this patent protects
The invention relates to compounds of the formula (I), wherein X, R1, R2, R3, R4 and R5 have the meaning indicated in claim 1. The inventive compounds represent inhibitors of the subtype 3 sodium/proton exchanger (NHE-3).
USPTO Abstract
The invention relates to compounds of the formula (I), wherein X, R1, R2, R3, R4 and R5 have the meaning indicated in claim 1. The inventive compounds represent inhibitors of the subtype 3 sodium/proton exchanger (NHE-3).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.